Adicet Bio, Inc. (ACET) has 9 SEC Form 4 insider filings on record in the last 90 days. Most recent filing: Aug. 7, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Aug. 7, 2026 filed Aug. 5, 2026 | Klickstein Lloyd Chief Medical Officer | $0 | 18,300 | 0% | No | |
|
|
||||||
| June 23, 2026 filed June 19, 2026 | Schor Chen President & CEO | $0 | 55,000 | 0% | No | |
|
|
||||||
| June 23, 2026 filed June 19, 2026 | Aftab Blake Chief Scientific Officer | $0 | 55,000 | 0% | No | |
|
|
||||||
| June 23, 2026 filed June 21, 2026 | DUBIN STEVE Director | $0 | 4,200 | 0% | No | |
|
|
||||||
| June 23, 2026 filed June 21, 2026 | Chodakewitz Jeffrey Director | $0 | 4,200 | 0% | No | |
|
|
||||||
Showing the 5 most recent of 9 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free